APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucocorticoids

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glucocorticoids Industry Growth and Trends Forecast to 2032

22 December 2025102 pages

Choose your research edition.

Industry ResearchGlucocorticoids Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucocorticoids Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Glucocorticoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucocorticoids Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucocorticoids Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Glucocorticoids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glucocorticoids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glucocorticoids is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucocorticoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucocorticoids include Zhejiang Xianju Pharmaceutical Co.,Ltd, Yangzi River Pharmaceutical Group, Shandong Xinhua Pharmaceutical Company Limited, Sanofi, Novartis, Tianjin Tianyao Pharmaceuticals Co., Ltd., Pfizer, Symbiotec and Euroapi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glucocorticoids market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glucocorticoids market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glucocorticoids market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glucocorticoids.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glucocorticoids market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glucocorticoids Market by Company

Zhejiang Xianju Pharmaceutical Co.,Ltd

Yangzi River Pharmaceutical Group

Shandong Xinhua Pharmaceutical Company Limited

Sanofi

Novartis

Tianjin Tianyao Pharmaceuticals Co., Ltd.

Pfizer

Symbiotec

Euroapi

Cipla

Avik Pharmaceutical Limited

Aspen

Abbott Laboratories

Glucocorticoids Segment by Type

Hydrocortisone

Prednisone

Prednisolone

Cortisone

Methylprednisolone

Dexamethasone

Betamethasone

Others

Glucocorticoids Segment by Application

Vasoconstrictive

Immunosuppressive

Anti-inflammatory

Glucocorticoids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucocorticoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucocorticoids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucocorticoids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucocorticoids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glucocorticoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hydrocortisone Table 2. Major Company of Prednisone Table 3. Major Company of Prednisolone Table 4. Major Company of Cortisone Table 5. Major Company of Methylprednisolone Table 6. Major Company of Dexamethasone Table 7. Major Company of Betamethasone Table 8. Major Company of Others Table 9. Global Glucocorticoids Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 10. Global Glucocorticoids Sales by Type (2021-2026) & (k units) Table 11. Global Glucocorticoids Sales Market Share in Volume by Type (2021-2026) Table 12. Global Glucocorticoids Sales by Type (2021-2026) & (US$ Million) Table 13. Global Glucocorticoids Sales Market Share in Value by Type (2021-2026) Table 14. Global Glucocorticoids Price by Type (2021-2026) & (US$/unit) Table 15. Global Glucocorticoids Sales by Type (2027-2032) & (k units) Table 16. Global Glucocorticoids Sales Market Share in Volume by Type (2027-2032) Table 17. Global Glucocorticoids Sales by Type (2027-2032) & (US$ Million) Table 18. Global Glucocorticoids Sales Market Share in Value by Type (2027-2032) Table 19. Global Glucocorticoids Price by Type (2027-2032) & (US$/unit) Table 20. North America Glucocorticoids Sales by Type (2021-2026) & (k units) Table 21. North America Glucocorticoids Sales by Type (2021-2026) & (US$ Million) Table 22. Europe Glucocorticoids Sales by Type (2021-2026) & (k units) Table 23. Europe Glucocorticoids Sales by Type (2021-2026) & (US$ Million) Table 24. Asia-Pacific Glucocorticoids Sales by Type (2021-2026) & (k units) Table 25. Asia-Pacific Glucocorticoids Sales by Type (2021-2026) & (US$ Million) Table 26. Latin America Glucocorticoids Sales by Type (2021-2026) & (k units) Table 27. Latin America Glucocorticoids Sales by Type (2021-2026) & (US$ Million) Table 28. Middle East and Africa Glucocorticoids Sales by Type (2021-2026) & (k units) Table 29. Middle East and Africa Glucocorticoids Sales by Type (2021-2026) & (US$ Million) Table 30. Glucocorticoids Industry Trends Table 31. Glucocorticoids Industry Drivers Table 32. Glucocorticoids Industry Opportunities and Challenges Table 33. Glucocorticoids Industry Restraints Table 34. Global Glucocorticoids Sales Revenue by Company (US$ Million) & (2021-2026) Table 35. Global Glucocorticoids Revenue Market Share by Company (2021-2026) Table 36. Global Glucocorticoids Sales by Company (2021-2026) & (k units) Table 37. Global Glucocorticoids Sales Share by Company (2021-2026) Table 38. Global Glucocorticoids Market Price by Company (2021-2026) & (US$/unit) Table 39. Global Glucocorticoids Industry Company Ranking, 2024 VS 2025 VS 2026 Table 40. Global Glucocorticoids Major Company Production Sites and Headquarters Table 41. Global Glucocorticoids Company, Product Type & Application Table 42. Global Glucocorticoids Company Establishment Date Table 43. Global Company Market Concentration Ratio (CR5 and HHI) Table 44. Global Glucocorticoids by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 45. Global Glucocorticoids Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 46. Global Glucocorticoids Sales by Region (2021-2026) & (k units) Table 47. Global Glucocorticoids Sales Market Share in Volume by Region (2021-2026) Table 48. Global Glucocorticoids Sales by Region (2021-2026) & (US$ Million) Table 49. Global Glucocorticoids Sales Market Share in Value by Region (2021-2026) Table 50. Global Glucocorticoids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Global Glucocorticoids Sales by Region (2027-2032) & (k units) Table 52. Global Glucocorticoids Sales Market Share in Volume by Region (2027-2032) Table 53. Global Glucocorticoids Sales by Region (2027-2032) & (US$ Million) Table 54. Global Glucocorticoids Sales Market Share in Value by Region (2027-2032) Table 55. Global Glucocorticoids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 56. Global Glucocorticoids Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 57. Global Glucocorticoids Sales by Application (2021-2026) & (k units) Table 58. Global Glucocorticoids Sales Market Share in Volume by Application (2021-2026) Table 59. Global Glucocorticoids Sales by Application (2021-2026) & (US$ Million) Table 60. Global Glucocorticoids Sales Market Share in Value by Application (2021-2026) Table 61. Global Glucocorticoids Price by Application (2021-2026) & (US$/unit) Table 62. Global Glucocorticoids Sales by Application (2027-2032) & (k units) Table 63. Global Glucocorticoids Sales Market Share in Volume by Application (2027-2032) Table 64. Global Glucocorticoids Sales by Application (2027-2032) & (US$ Million) Table 65. Global Glucocorticoids Sales Market Share in Value by Application (2027-2032) Table 66. Global Glucocorticoids Price by Application (2027-2032) & (US$/unit) Table 67. North America Glucocorticoids Sales by Application (2021-2026) & (k units) Table 68. North America Glucocorticoids Sales by Application (2021-2026) & (US$ Million) Table 69. Europe Glucocorticoids Sales by Application (2021-2026) & (k units) Table 70. Europe Glucocorticoids Sales by Application (2021-2026) & (US$ Million) Table 71. Asia-Pacific Glucocorticoids Sales by Application (2021-2026) & (k units) Table 72. Asia-Pacific Glucocorticoids Sales by Application (2021-2026) & (US$ Million) Table 73. Latin America Glucocorticoids Sales by Application (2021-2026) & (k units) Table 74. Latin America Glucocorticoids Sales by Application (2021-2026) & (US$ Million) Table 75. Middle East and Africa Glucocorticoids Sales by Application (2021-2026) & (k units) Table 76. Middle East and Africa Glucocorticoids Sales by Application (2021-2026) & (US$ Million) Table 77. Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information Table 78. Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview Table 79. Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Product Portfolio Table 81. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Development Table 82. Yangzi River Pharmaceutical Group Company Information Table 83. Yangzi River Pharmaceutical Group Business Overview Table 84. Yangzi River Pharmaceutical Group Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Yangzi River Pharmaceutical Group Glucocorticoids Product Portfolio Table 86. Yangzi River Pharmaceutical Group Recent Development Table 87. Shandong Xinhua Pharmaceutical Company Limited Company Information Table 88. Shandong Xinhua Pharmaceutical Company Limited Business Overview Table 89. Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Product Portfolio Table 91. Shandong Xinhua Pharmaceutical Company Limited Recent Development Table 92. Sanofi Company Information Table 93. Sanofi Business Overview Table 94. Sanofi Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Sanofi Glucocorticoids Product Portfolio Table 96. Sanofi Recent Development Table 97. Novartis Company Information Table 98. Novartis Business Overview Table 99. Novartis Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Novartis Glucocorticoids Product Portfolio Table 101. Novartis Recent Development Table 102. Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information Table 103. Tianjin Tianyao Pharmaceuticals Co., Ltd. Business Overview Table 104. Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Product Portfolio Table 106. Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Pfizer Glucocorticoids Product Portfolio Table 111. Pfizer Recent Development Table 112. Symbiotec Company Information Table 113. Symbiotec Business Overview Table 114. Symbiotec Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Symbiotec Glucocorticoids Product Portfolio Table 116. Symbiotec Recent Development Table 117. Euroapi Company Information Table 118. Euroapi Business Overview Table 119. Euroapi Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Euroapi Glucocorticoids Product Portfolio Table 121. Euroapi Recent Development Table 122. Cipla Company Information Table 123. Cipla Business Overview Table 124. Cipla Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Cipla Glucocorticoids Product Portfolio Table 126. Cipla Recent Development Table 127. Avik Pharmaceutical Limited Company Information Table 128. Avik Pharmaceutical Limited Business Overview Table 129. Avik Pharmaceutical Limited Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Avik Pharmaceutical Limited Glucocorticoids Product Portfolio Table 131. Avik Pharmaceutical Limited Recent Development Table 132. Aspen Company Information Table 133. Aspen Business Overview Table 134. Aspen Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Aspen Glucocorticoids Product Portfolio Table 136. Aspen Recent Development Table 137. Abbott Laboratories Company Information Table 138. Abbott Laboratories Business Overview Table 139. Abbott Laboratories Glucocorticoids Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Abbott Laboratories Glucocorticoids Product Portfolio Table 141. Abbott Laboratories Recent Development Table 142. North America Glucocorticoids Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. North America Glucocorticoids Sales by Country (2021-2026) & (k units) Table 144. North America Glucocorticoids Sales Market Share by Country (2021-2026) Table 145. North America Glucocorticoids Sales Forecast by Country (2027-2032) & (k units) Table 146. North America Glucocorticoids Sales Market Share Forecast by Country (2027-2032) Table 147. North America Glucocorticoids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Glucocorticoids Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Glucocorticoids Market Share by Country (2021-2026) Table 150. North America Glucocorticoids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Glucocorticoids Market Share Forecast by Country (2027-2032) Table 152. Europe Glucocorticoids Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Europe Glucocorticoids Sales by Country (2021-2026) & (k units) Table 154. Europe Glucocorticoids Sales Market Share by Country (2021-2026) Table 155. Europe Glucocorticoids Sales Forecast by Country (2027-2032) & (k units) Table 156. Europe Glucocorticoids Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Glucocorticoids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Glucocorticoids Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Glucocorticoids Market Share by Country (2021-2026) Table 160. Europe Glucocorticoids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Glucocorticoids Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Glucocorticoids Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Glucocorticoids Sales by Country (2021-2026) & (k units) Table 164. Asia-Pacific Glucocorticoids Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Glucocorticoids Sales Forecast by Country (2027-2032) & (k units) Table 166. Asia-Pacific Glucocorticoids Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Glucocorticoids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Glucocorticoids Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Glucocorticoids Market Share by Country (2021-2026) Table 170. Asia-Pacific Glucocorticoids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Glucocorticoids Market Share Forecast by Country (2027-2032) Table 172. Latin America Glucocorticoids Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Latin America Glucocorticoids Sales by Country (2021-2026) & (k units) Table 174. Latin America Glucocorticoids Sales Market Share by Country (2021-2026) Table 175. Latin America Glucocorticoids Sales Forecast by Country (2027-2032) & (k units) Table 176. Latin America Glucocorticoids Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Glucocorticoids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Glucocorticoids Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Glucocorticoids Market Share by Country (2021-2026) Table 180. Latin America Glucocorticoids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Glucocorticoids Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Glucocorticoids Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Glucocorticoids Sales by Country (2021-2026) & (k units) Table 184. Middle East and Africa Glucocorticoids Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Glucocorticoids Sales Forecast by Country (2027-2032) & (k units) Table 186. Middle East and Africa Glucocorticoids Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Glucocorticoids Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Glucocorticoids Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Glucocorticoids Market Share by Country (2021-2026) Table 190. Middle East and Africa Glucocorticoids Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Glucocorticoids Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Glucocorticoids Distributors List Table 195. Glucocorticoids Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Glucocorticoids Image Figure 2. Global Glucocorticoids Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucocorticoids Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucocorticoids Sales (2021-2032) & (k units) Figure 5. Hydrocortisone Image Figure 6. Global Hydrocortisone Sales YoY Growth (2021-2032) & (k units) Figure 7. Prednisone Image Figure 8. Global Prednisone Sales YoY Growth (2021-2032) & (k units) Figure 9. Prednisolone Image Figure 10. Global Prednisolone Sales YoY Growth (2021-2032) & (k units) Figure 11. Cortisone Image Figure 12. Global Cortisone Sales YoY Growth (2021-2032) & (k units) Figure 13. Methylprednisolone Image Figure 14. Global Methylprednisolone Sales YoY Growth (2021-2032) & (k units) Figure 15. Dexamethasone Image Figure 16. Global Dexamethasone Sales YoY Growth (2021-2032) & (k units) Figure 17. Betamethasone Image Figure 18. Global Betamethasone Sales YoY Growth (2021-2032) & (k units) Figure 19. Others Image Figure 20. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 21. Global Glucocorticoids Market Size Overview by Type (2021-2032) & (US$ Million) Figure 22. Global Glucocorticoids Market Share by Type 2025 VS 2032 Figure 23. North America Glucocorticoids Sales Market Share in Volume by Type in 2025 Figure 24. North America Glucocorticoids Sales Market Share in Value by Type in 2025 Figure 25. Europe Glucocorticoids Sales Market Share in Volume by Type in 2025 Figure 26. Europe Glucocorticoids Sales Market Share in Value by Type in 2025 Figure 27. Asia-Pacific Glucocorticoids Sales Market Share in Volume by Type in 2025 Figure 28. Asia-Pacific Glucocorticoids Sales Market Share in Value by Type in 2025 Figure 29. Latin America Glucocorticoids Sales Market Share in Volume by Type in 2025 Figure 30. Latin America Glucocorticoids Sales Market Share in Value by Type in 2025 Figure 31. Middle East and Africa Glucocorticoids Sales Market Share in Volume by Type in 2025 Figure 32. Middle East and Africa Glucocorticoids Sales Market Share in Value by Type in 2025 Figure 33. Global Top 5 and 10 Glucocorticoids Players Market Share by Revenue in 2025 Figure 34. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Vasoconstrictive Image Figure 36. Global Vasoconstrictive Sales YoY Growth (2021-2032) & (k units) Figure 37. Immunosuppressive Image Figure 38. Global Immunosuppressive Sales YoY Growth (2021-2032) & (k units) Figure 39. Anti-inflammatory Image Figure 40. Global Anti-inflammatory Sales YoY Growth (2021-2032) & (k units) Figure 41. Global Glucocorticoids Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Glucocorticoids Market Share by Application 2025 VS 2032 Figure 43. North America Glucocorticoids Sales Market Share in Volume by Application in 2025 Figure 44. North America Glucocorticoids Sales Market Share in Value by Application in 2025 Figure 45. Europe Glucocorticoids Sales Market Share in Volume by Application in 2025 Figure 46. Europe Glucocorticoids Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Glucocorticoids Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Glucocorticoids Sales Market Share in Value by Application in 2025 Figure 49. Latin America Glucocorticoids Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Glucocorticoids Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Glucocorticoids Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Glucocorticoids Sales Market Share in Value by Application in 2025 Figure 53. North America Glucocorticoids Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. North America Glucocorticoids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Glucocorticoids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Glucocorticoids Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Glucocorticoids Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Europe Glucocorticoids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Glucocorticoids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Glucocorticoids Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Glucocorticoids Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Asia-Pacific Glucocorticoids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Glucocorticoids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Glucocorticoids Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Glucocorticoids Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Latin America Glucocorticoids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Glucocorticoids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Glucocorticoids Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Glucocorticoids Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 70. Middle East and Africa Glucocorticoids Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Glucocorticoids Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Glucocorticoids Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Glucocorticoids Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Glucocorticoids Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Hydrocortisone
  • Prednisone
  • Prednisolone
  • Cortisone
  • Methylprednisolone
  • Dexamethasone
  • Betamethasone
  • Others
Applications
  • Vasoconstrictive
  • Immunosuppressive
  • Anti-inflammatory
Companies covered
  • Zhejiang Xianju Pharmaceutical Co.,Ltd
  • Yangzi River Pharmaceutical Group
  • Shandong Xinhua Pharmaceutical Company Limited
  • Sanofi
  • Novartis
  • Tianjin Tianyao Pharmaceuticals Co., Ltd.
  • Pfizer
  • Symbiotec
  • Euroapi
  • Cipla
  • Avik Pharmaceutical Limited
  • Aspen
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucocorticoids Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glucocorticoids Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glucocorticoids Market by Type
  6. 1.3.1 Hydrocortisone
  7. 1.3.2 Prednisone
  8. 1.3.3 Prednisolone
  9. 1.3.4 Cortisone
  10. 1.3.5 Methylprednisolone
  11. 1.3.6 Dexamethasone
  12. 1.3.7 Betamethasone
  13. 1.3.8 Others
  14. 1.4 Global Glucocorticoids Market Size by Type
  15. 1.4.1 Global Glucocorticoids Market Size Overview by Type (2021-2032)
  16. 1.4.2 Global Glucocorticoids Historic Market Size Review by Type (2021-2026)
  17. 1.4.3 Global Glucocorticoids Forecasted Market Size by Type (2027-2032)
  18. 1.5 Key Regions Market Size by Type
  19. 1.5.1 North America Glucocorticoids Sales Breakdown by Type (2021-2026)
  20. 1.5.2 Europe Glucocorticoids Sales Breakdown by Type (2021-2026)
  21. 1.5.3 Asia-Pacific Glucocorticoids Sales Breakdown by Type (2021-2026)
  22. 1.5.4 South America Glucocorticoids Sales Breakdown by Type (2021-2026)
  23. 1.5.5 Middle East and Africa Glucocorticoids Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glucocorticoids Industry Trends
  2. 2.2 Glucocorticoids Industry Drivers
  3. 2.3 Glucocorticoids Industry Opportunities and Challenges
  4. 2.4 Glucocorticoids Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glucocorticoids Revenue (2021-2026)
  2. 3.2 Global Top Players by Glucocorticoids Sales (2021-2026)
  3. 3.3 Global Top Players by Glucocorticoids Price (2021-2026)
  4. 3.4 Global Glucocorticoids Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucocorticoids Major Company Production Sites & Headquarters
  6. 3.6 Global Glucocorticoids Company, Product Type & Application
  7. 3.7 Global Glucocorticoids Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucocorticoids Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucocorticoids Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucocorticoids Tier 1, Tier 2, and Tier 3
4 Glucocorticoids Regional Status and Outlook
  1. 4.1 Global Glucocorticoids Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glucocorticoids Historic Market Size by Region
  3. 4.2.1 Global Glucocorticoids Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glucocorticoids Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glucocorticoids Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glucocorticoids Forecasted Market Size by Region
  7. 4.3.1 Global Glucocorticoids Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glucocorticoids Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glucocorticoids Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glucocorticoids by Application
  1. 5.1 Glucocorticoids Market by Application
  2. 5.1.1 Vasoconstrictive
  3. 5.1.2 Immunosuppressive
  4. 5.1.3 Anti-inflammatory
  5. 5.2 Global Glucocorticoids Market Size by Application
  6. 5.2.1 Global Glucocorticoids Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Glucocorticoids Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Glucocorticoids Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Glucocorticoids Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Glucocorticoids Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Glucocorticoids Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Glucocorticoids Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Glucocorticoids Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Xianju Pharmaceutical Co.,Ltd
  2. 6.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information
  3. 6.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview
  4. 6.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Product Portfolio
  6. 6.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments
  7. 6.2 Yangzi River Pharmaceutical Group
  8. 6.2.1 Yangzi River Pharmaceutical Group Company Information
  9. 6.2.2 Yangzi River Pharmaceutical Group Business Overview
  10. 6.2.3 Yangzi River Pharmaceutical Group Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yangzi River Pharmaceutical Group Glucocorticoids Product Portfolio
  12. 6.2.5 Yangzi River Pharmaceutical Group Recent Developments
  13. 6.3 Shandong Xinhua Pharmaceutical Company Limited
  14. 6.3.1 Shandong Xinhua Pharmaceutical Company Limited Company Information
  15. 6.3.2 Shandong Xinhua Pharmaceutical Company Limited Business Overview
  16. 6.3.3 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Product Portfolio
  18. 6.3.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Glucocorticoids Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Glucocorticoids Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Tianjin Tianyao Pharmaceuticals Co., Ltd.
  32. 6.6.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information
  33. 6.6.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Business Overview
  34. 6.6.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Product Portfolio
  36. 6.6.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Glucocorticoids Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Symbiotec
  44. 6.8.1 Symbiotec Company Information
  45. 6.8.2 Symbiotec Business Overview
  46. 6.8.3 Symbiotec Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Symbiotec Glucocorticoids Product Portfolio
  48. 6.8.5 Symbiotec Recent Developments
  49. 6.9 Euroapi
  50. 6.9.1 Euroapi Company Information
  51. 6.9.2 Euroapi Business Overview
  52. 6.9.3 Euroapi Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Euroapi Glucocorticoids Product Portfolio
  54. 6.9.5 Euroapi Recent Developments
  55. 6.10 Cipla
  56. 6.10.1 Cipla Company Information
  57. 6.10.2 Cipla Business Overview
  58. 6.10.3 Cipla Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cipla Glucocorticoids Product Portfolio
  60. 6.10.5 Cipla Recent Developments
  61. 6.11 Avik Pharmaceutical Limited
  62. 6.11.1 Avik Pharmaceutical Limited Company Information
  63. 6.11.2 Avik Pharmaceutical Limited Business Overview
  64. 6.11.3 Avik Pharmaceutical Limited Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Avik Pharmaceutical Limited Glucocorticoids Product Portfolio
  66. 6.11.5 Avik Pharmaceutical Limited Recent Developments
  67. 6.12 Aspen
  68. 6.12.1 Aspen Company Information
  69. 6.12.2 Aspen Business Overview
  70. 6.12.3 Aspen Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Aspen Glucocorticoids Product Portfolio
  72. 6.12.5 Aspen Recent Developments
  73. 6.13 Abbott Laboratories
  74. 6.13.1 Abbott Laboratories Company Information
  75. 6.13.2 Abbott Laboratories Business Overview
  76. 6.13.3 Abbott Laboratories Glucocorticoids Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Abbott Laboratories Glucocorticoids Product Portfolio
  78. 6.13.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Glucocorticoids Sales by Country
  2. 7.1.1 North America Glucocorticoids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glucocorticoids Sales by Country (2021-2026)
  4. 7.1.3 North America Glucocorticoids Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glucocorticoids Market Size by Country
  6. 7.2.1 North America Glucocorticoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glucocorticoids Market Size by Country (2021-2026)
  8. 7.2.3 North America Glucocorticoids Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glucocorticoids Sales by Country
  2. 8.1.1 Europe Glucocorticoids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glucocorticoids Sales by Country (2021-2026)
  4. 8.1.3 Europe Glucocorticoids Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glucocorticoids Market Size by Country
  6. 8.2.1 Europe Glucocorticoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glucocorticoids Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glucocorticoids Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glucocorticoids Sales by Country
  2. 9.1.1 Asia-Pacific Glucocorticoids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glucocorticoids Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glucocorticoids Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glucocorticoids Market Size by Country
  6. 9.2.1 Asia-Pacific Glucocorticoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glucocorticoids Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glucocorticoids Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glucocorticoids Sales by Country
  2. 10.1.1 South America Glucocorticoids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glucocorticoids Sales by Country (2021-2026)
  4. 10.1.3 South America Glucocorticoids Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glucocorticoids Market Size by Country
  6. 10.2.1 South America Glucocorticoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glucocorticoids Market Size by Country (2021-2026)
  8. 10.2.3 South America Glucocorticoids Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glucocorticoids Sales by Country
  2. 11.1.1 Middle East and Africa Glucocorticoids Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glucocorticoids Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glucocorticoids Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glucocorticoids Market Size by Country
  6. 11.2.1 Middle East and Africa Glucocorticoids Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glucocorticoids Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glucocorticoids Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glucocorticoids Value Chain Analysis
  2. 12.1.1 Glucocorticoids Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glucocorticoids Production Mode & Process
  7. 12.2 Glucocorticoids Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glucocorticoids Distributors
  10. 12.2.3 Glucocorticoids Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst